1 / 2

Schizophrenia Drugs Market Is Predicted To Reach USD 9.48 Billion By 2026

Schizophrenia Drugs Market: Rising Safety For The Treatment of Schizophrenia Will Fuel Demand Among Patients

saurabhrj
Download Presentation

Schizophrenia Drugs Market Is Predicted To Reach USD 9.48 Billion By 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Title : Schizophrenia Drugs Market Will Exhibit a CAGR of 4.3%; Rising Awareness Regarding Mental Health Will EnableGrowth Schizophrenia Drugs Market Is Predicted To Reach USD 9.48 Billion By 2026 Description : Schizophrenia Drugs Market: Rising Safety For The Treatment of Schizophrenia Will Fuel Demand AmongPatients Content: The increasing prevalence of chronic and mental disorder is a key factor expected to enable growth in the global schizophrenia drugs market, says Fortune Business Insights in a report, titled “Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026.” The global schizophrenia drugs market was valued at USD 6.75 Billion in 2018 and is projected to reach USD 9.48 Billion by 2026, exhibiting a CAGR of 4.3% during the forecastperiod. An Overview of the Impact of COVID-19 on thisMarket: The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses acrossindustries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic. We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for thefuture. Click here to get the short-term and long-term impact of COVID-19 on this[Market]. For More Information : https://www.fortunebusinessinsights.com/industry- reports/schizophrenia-drugs-market-101531 Rising Awareness About Mental Disorders Will BoostGrowth According to Fortune Business Insights, the increasing cases of mental disorders such as schizophrenia will uplift the global schizophrenia drugs market shares. The surge in medical interventions for the treatment of major mental disorders will enable growth inthe global schizophrenia drugs market during the forecast period. Furthermore, the rising emphasis on mental illness and mental health in emerging nations will boost the global schizophrenia drugs market revenue during the forecast period. Moreover, the increasing efficacy and safety features of treatment for schizophrenia will fuel demand among patients which,willin turn,accelerate the growth of the global schizophrenia drugs.

  2. Launch Of REXULTI Tablets Will PropelGrowth Otsuka Pharmaceutical Co., Ltd., a pharmaceutical company headquartered in Tokyo launched REXULTI Tablets (chemical name is brexpiprazole) in 1 mg and 2 mg tablets for the treatment of schizophrenia in patients. Based on the efficacy of REXULTI in the treatment of schizophrenia, it is included in the Japanese National Health Insurance Drug Price List. The launch of REXULTI® Tablets will favor growth to the global schizophrenia drugs market owing to the presence of a novel compound in the tablets. REXULTI Tablets will be marketed to healthcare institutions across Japan to treat patients with mentaldisorders. Furthermore, according to the report published by Fortune Business Insights on the basis of treatment outlook the global schizophrenia drugs market is segmented into oral and injectable. Injectedbale based treatment is predicted to generate maximum revenue owing to the prevention of relapses and also the irreparable cognitive and neurological damages to thepatients. More Trending Topics From Fortune BusinessInsights@ Coronary Guidewires Market, Share, Growth, Sales and Drivers Analysis Research Report 2026 Coronary Guidewires Market to Reach $ 594.8 Million by 2026; Presence ofFavorable Health Reimbursement Policies to Aid Growth, says Fortune Business Insights™

More Related